Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRONULIFE Effenergy
- Development stage
- Unknown
- Lead developer
- Glac Biotech
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
PRONULIFE Effenergy is a functional probiotic ingredient blend developed by GLAC Biotech Co., Ltd. (豐華生物科技) for use in dietary supplements and functional foods. The product consists of three specific probiotic strains: *Bifidobacterium longum* subsp. *longum* OLP-01, *Lactobacillus plantarum* PL-02, and *Lactococcus lactis* LY-66, which were originally isolated from the gut microbiota of an Olympic gold medalist. It is clinically designed to support energy, stamina, and sports performance by enhancing muscle strength, accelerating lactate metabolism, and reducing biochemical markers of post-exercise fatigue such as blood urea nitrogen (BUN), ammonia, and creatine kinase. The product has been validated through clinical studies, including double-blind, placebo-controlled trials in distance runners, and is typically administered orally as a powder.
- Brand names
- PRONULIFE Effenergy
- Other names
- Effenergy
Beyond the preview
Go deeper on PRONULIFE Effenergy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRONULIFE Effenergy.